logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain.

    Article - En anglais

    The human T-lymphotropic virus type II (HTLV-II) has recently been associated with the genesis of some subacute neurological syndromes and, rarely, with atypical T-lymphoid malignancies.

    The virus is endemic in some Amerindian and African tribes, and among intravenous drug users (IDUs) in North America and Europe.

    Given that HTLV-II is transmitted by the same routes as other human retroviruses, the screening of antibodies to HTLV-II in blood donors has became a matter of controversy in some countries.

    Herein, we describe the clinical, epidemiological and virological features of 113 individuals with HTLV-II infection identified in Spain up to September 1995.

    Most of them (94/113 ; 83%) were male, and all but seven were natives.

    Four were African immigrants living in Madrid and 3 had been born in other European countries.

    All but six subjects were IDUs, and sexual transmission of HTLV-II and transfusion were involved in five and one individual, respectively.

    Eighty-four percent of the IDUs infected with HTLV-II were co-infected by HIV-1 (93/107).

    Clinical manifestations potentially linked to HTLV-II were absent, although an IDU male co-infected by HIV-I and HTLV-II developed a severe non-inflammatory proximal myopathy.

    In conclusion, HTLV-II infection is present in Spain, mainly among IDUs, with a growing incidence and a current overall prevalence of 2.0 percent.

    Mots-clés Pascal : Virus HTLV2, Retroviridae, Virus, Infection, Symptomatologie, Epidémiologie, Diagnostic, Homme, Espagne, Europe

    Mots-clés Pascal anglais : HTLV-II virus, Retroviridae, Virus, Infection, Symptomatology, Epidemiology, Diagnosis, Human, Spain, Europe

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0056014

    Code Inist : 002B05C02J. Création : 21/05/1997.